Ischemic Attack, Transient Clinical Trial
Official title:
Cognitive and Physical Functions in Patients With TIA. A Randomized Controlled Trial of Physical Activity on Prescription up to One Year After the Event
The purpose of this study is to determine whether Physical Activation on Prescription can
help patients with TIA to become more physically active.
One group will receives Physical Activation on Prescription (PaP)and the other group will
receives usual care.
And to identify if persons with TIA presents with cognitive impairments.
Status | Active, not recruiting |
Enrollment | 100 |
Est. completion date | July 2015 |
Est. primary completion date | April 2015 |
Accepts healthy volunteers | No |
Gender | Both |
Age group | N/A and older |
Eligibility |
Inclusion Criteria: - Understand Swedish language (also in and writing), living in Norrtälje community, - To participate in the assessment of cognitive function: no known cognitive impairments before the TIA event and history of stroke. Exclusion Criteria: - Presence of contraindications to exercise, and no history of stroke |
Allocation: Randomized, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment
Country | Name | City | State |
---|---|---|---|
Sweden | Tiohundra | Norrtälje | Stockholms Läns Landsting |
Lead Sponsor | Collaborator |
---|---|
Tiohundra AB | Karolinska Institutet |
Sweden,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Change in Physical activity over time | Physical activity measured with accelerometer (Time frame: Baseline, 3, 6, and 12 month). | at discharge from hospital, 3, 6 and 12 month after the event | No |
Secondary | Change in Cognition and Mental Fatigue | Change in mental conditions over time measured with self report of mental fatigue and related symptoms. This is a scale with 7 different steps for graduate mental fatigue. Less points indicate less mental fatigue. | All measures at baseline 3, 6 and 12 month after the event | No |
Secondary | Change in 6 MWT | Change in Walking endurance measured in 3, 6, 12 month measured with 6 MWT (six minutes Walking Test). | 3, 6 and 12 months | No |
Secondary | Change in self reported stages of change | A self reported questionnaire that measures willingness to changes in physical activity over time. The scale has different levels of willingness for changes in physical activity. | 3, 6, 12 months | No |
Secondary | Change from baseline in systolic blood pressure at 12 months | 3, 6, 12 months | No | |
Secondary | BMI | Body Mass Index is measured at the start and at the end of the study | 12 months | No |
Secondary | Change in mental capacity over a period of time | Change in mental capacity measured with a assessment called Cognistat that indicates four different levels of mental capacity. | 3, 6,12 months | No |
Secondary | Change in mental capacity over a period of time | Change in mental capacity measured with a assessment called Cognistat that indicates four different levels of mental capacity. | 3, 6, 12 months | No |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT02141932 -
Pocket-size Cardiovascular Ultrasound in Stroke
|
N/A | |
Recruiting |
NCT02662751 -
Performing a Low-dose, Whole-body Angiography as the First Element of an Imaging Assessment Following Stroke / TIA
|
N/A | |
Completed |
NCT02038725 -
MIDNOR-TIA - a Study of 600 Patients With Transient Ischemic Attack
|
||
Completed |
NCT01528462 -
Sleep Disorders Managed and Assessed Rapidly in Transient Ischemic Attack (TIA) and In Early Stroke
|
||
Withdrawn |
NCT00069069 -
E-Selectin Nasal Instillation to Prevent Secondary Stroke
|
Phase 1 | |
Recruiting |
NCT02701998 -
The Stroke and Exercise Program
|
N/A | |
Completed |
NCT02450760 -
Connected Health Blood Pressure Monitoring In Stroke and TIA Patients
|
N/A | |
Completed |
NCT02089074 -
Systematic Follow up of Drug Treatment by Pharmacists in Secondary Prevention After Transient Ischemic Attack
|
N/A | |
Completed |
NCT00250380 -
The Study on Profile and Genetic Factors of Aspirin Resistance (ProGEAR Study)
|
Phase 4 | |
Terminated |
NCT00991029 -
Platelet-Oriented Inhibition in New TIA and Minor Ischemic Stroke (POINT) Trial
|
Phase 3 | |
Recruiting |
NCT06407154 -
Chronical Illness-related Limitations of the Ability to Cope With Rising Temperatures: an Observational Study, 2nd Wave
|
||
Completed |
NCT00061022 -
Safety and Effectiveness of NXY-059 for the Treatment of Patients Who Have Suffered From a Stroke
|
Phase 3 | |
Completed |
NCT02799511 -
Biomarkers for the Diagnosis of Transient Ischemic Attack
|
N/A | |
Completed |
NCT02415855 -
Canadian Pradaxa Acute Stroke Safety Study
|
||
Completed |
NCT00514800 -
Home Blood Pressure Monitoring Trial
|
Phase 3 | |
Recruiting |
NCT00553241 -
Short-Term Prognosis Evaluation of Transient Ischemic Attack Patients Using ABCD2 Score
|
N/A | |
Active, not recruiting |
NCT00201461 -
Evaluation of the STARFlex® Septal Closure System in Patients With a Stroke or TIA Due to the Possible Passage of a Clot of Unknown Origin Through a Patent Foramen Ovale (PFO)
|
Phase 2/Phase 3 | |
Completed |
NCT00119626 -
Safety and Effectiveness of NXY-059 for the Treatment of Patients Who Have Suffered From a Stroke
|
Phase 3 | |
Terminated |
NCT05961163 -
Chronical Illness-related Limitations of the Ability to Cope With Rising Temperatures: an Observational Study
|
||
Completed |
NCT00590980 -
Vertebrobasilar Flow Evaluation and Risk of Transient Ischemic Attack and Stroke (VERiTAS)
|
N/A |